Prince Pharmaceutical Co., Ltd. logo

Prince Pharmaceutical Co., Ltd. (6935)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
31. 30
+0.05
+0.16%
NT$
836.42M Market Cap
- P/E Ratio
1% Div Yield
3,070 Volume
- Eps
NT$ 31.25
Previous Close
Add Transaction
Day Range
29.95 31.35
Year Range
24.25 35.85
Want to track 6935 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Prince Pharmaceutical Co., Ltd. (6935) Statistics

Valuation metrics

Market Cap 836.42M
Enterprise value 1.45B
Trailing P/E (ttm) 12.12
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 1.12
Price/Book (mrq) 1.39
Enterprise Value/Revenue 1.37
Enterprise Value/EBITDA 8.23

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 63.52K
Average volume (90 days) 27.22K

Price summary

52-Week low 24.25
52-Week high 35.85
Beta -
50-Day moving average 30
200-Day moving average 29.56

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.5
Trailing annual dividend yield 0.0159%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 28 Jul 2026
Ex-Dividend Date 1 Jul 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.09%
Operating margin 0.1%

Operational effectiveness

Return on assets 0.06%
Return on equity 0.12%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 28.53
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.6
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 4.12
Total debt (mrq) -
Total Debt/Equity (mrq) 0.5
Current ratio (mrq) 1.81%
Book value per share (mrq) 22.65

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -